Phase 1 study of WT-1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Galinpepimut S (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 02 Dec 2015 New trial record
- 30 Nov 2015 Positive data were reported at the International WT1 Conference, as per Sellas Life Sciences media release.
- 30 Nov 2015 Results published in Sellas Life Sciences media release.